USA Today (9/24, Rodriguez) reports the FDA is requiring a “Boxed Warning” on all benzodiazepine products, which include Xanax (alprazolam) and Valium (diazepam), the agency announced Wednesday. These products must now include “warning labels that spell out the risks of abuse, misuse, addiction, physical dependence and withdrawal.” The agency, “in addition to the warning label…is also requiring changes to prescribing information on all products and existing patient Medication Guides.”
Medscape (9/24, Brooks, Subscription Publication) also covers the story.
Related Links:
— “FDA requires stronger warning label for Xanax, Valium and other similar benzodiazepine drugs “Adrianna Rodriguez, USA Today, September 24, 2020